Compile Data Set for Download or QSAR
Report error Found 445 Enz. Inhib. hit(s) with all data for entry = 7102
TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174595BDBM174595(US9102670, 14a)
Affinity DataIC50: 0.150nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174368BDBM174368(US9102670, 1cg)
Affinity DataIC50: 0.260nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174414BDBM174414(US9102670, 1du)
Affinity DataIC50: 0.390nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174467BDBM174467(US9102670, 4a)
Affinity DataIC50: 1.60nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174288BDBM174288(US9102670, 1c)
Affinity DataIC50: 1.84nMAssay Description:For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174287BDBM174287(US9102670, 1b)
Affinity DataIC50: 1.85nMAssay Description:For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174471BDBM174471(US9102670, 4e)
Affinity DataIC50: 1.90nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174472BDBM174472(US9102670, 4f)
Affinity DataIC50: 1.97nMAssay Description:For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174293BDBM174293(US9102670, 1h)
Affinity DataIC50: 2.10nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174289BDBM174289(US9102670, 1d)
Affinity DataIC50: 2.45nMAssay Description:For mTOR enzyme activity assays, mTOR protein was isolated from HeLa cell cytoplasmic extract by immunoprecipitation, and activity determined essenti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174413BDBM174413(US9102670, 1dt)
Affinity DataIC50: 2.60nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174686BDBM174686(US9102670, 18ca)
Affinity DataIC50: 2.60nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174472BDBM174472(US9102670, 4f)
Affinity DataIC50: 2.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174347BDBM174347(US9102670, 1bl)
Affinity DataIC50: 2.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174712BDBM174712(US9102670, 18db)
Affinity DataIC50: 3.10nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 50429706BDBM50429706(CHEMBL2336320 | US9102670, 14b)
Affinity DataIC50: 3.20nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174418BDBM174418(US9102670, 1dy)
Affinity DataIC50: 3.5nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174514BDBM174514(US9102670, 4av)
Affinity DataIC50: 3.80nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174602BDBM174602(US9102670, 15a)
Affinity DataIC50: 4.30nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174290BDBM174290(US9102670, 1e)
Affinity DataIC50: 4.40nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174360BDBM174360(US9102670, 1by)
Affinity DataIC50: 4.60nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174703BDBM174703(US9102670, 18cs)
Affinity DataIC50: 4.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174439BDBM174439(US9102670, 3e)
Affinity DataIC50: 4.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174424BDBM174424(US9102670, 1ee)
Affinity DataIC50: 4.80nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174767BDBM174767(US9102670, 1de)
Affinity DataIC50: 4.90nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174291BDBM174291(US9102670, 1f)
Affinity DataIC50: 5nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174357BDBM174357(US9102670, 1bv)
Affinity DataIC50: 5nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174441BDBM174441(US9102670, 3g)
Affinity DataIC50: 5.20nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174699BDBM174699(US9102670, 18co)
Affinity DataIC50: 5.20nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 60569BDBM60569(US9102670, 1dn)
Affinity DataIC50: 5.5nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174294BDBM174294(US9102670, 1i)
Affinity DataIC50: 5.60nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174296BDBM174296(US9102670, 1l)
Affinity DataIC50: 5.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174700BDBM174700(US9102670, 18cp)
Affinity DataIC50: 5.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174327BDBM174327(US9102670, 1ar)
Affinity DataIC50: 6nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174702BDBM174702(US9102670, 18cr)
Affinity DataIC50: 6.30nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174364BDBM174364(US9102670, 1cc)
Affinity DataIC50: 6.40nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 60571BDBM60571(US9102670, 1dp)
Affinity DataIC50: 6.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 60572BDBM60572(US9102670, 1az)
Affinity DataIC50: 6.87nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174314BDBM174314(US9102670, 1ad)
Affinity DataIC50: 6.90nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174480BDBM174480(US9102670, 4n)
Affinity DataIC50: 7.10nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174399BDBM174399(US9102670, 1dm)
Affinity DataIC50: 7.5nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174325BDBM174325(US9102670, 1ao)
Affinity DataIC50: 8.30nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174733BDBM174733(US9102670, 19g)
Affinity DataIC50: 8.70nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 50348452BDBM50348452(CHEMBL1801204 | US9102670, 1a | AZD-8055)
Affinity DataIC50: 8.90nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174478BDBM174478(US9102670, 4l)
Affinity DataIC50: 9.10nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174333BDBM174333(US9102670, 1ax)
Affinity DataIC50: 9.20nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174724BDBM174724(US9102670, 18dn)
Affinity DataIC50: 9.40nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174695BDBM174695(US9102670, 18ck)
Affinity DataIC50: 9.5nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 50429716BDBM50429716(CHEMBL2336332 | US9102670, 18bn)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Kudos Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 174685BDBM174685(US9102670, 18bz)
Affinity DataIC50: 10nMT: 2°CAssay Description:The assay used AlphaScreen technology (Gray et al., Analytical Biochemistry, 2003, 313: 234-245) to determine the ability of test compounds to inhibi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2016
Entry Details
US Patent

Displayed 1 to 50 (of 445 total ) | Next | Last >>
Jump to: